Swiss Life Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$776K Buy
10,985
+911
+9% +$49.2K ﹤0.01% 783
2026
Q1
$526K Buy
10,074
+2,548
+34% +$153K ﹤0.01% 843
2025
Q4
$443K Buy
7,526
+328
+5% +$19.9K ﹤0.01% 832
2025
Q3
$400K Sell
7,198
-370
-5% -$19.8K ﹤0.01% 791
2025
Q2
$389K Sell
7,568
-18,072
-70% -$908K ﹤0.01% 687
2025
Q1
$1.5M Buy
25,640
+5,733
+29% +$389K 0.01% 551
2024
Q4
$1.43M Buy
19,907
+17,077
+603% +$1.25M 0.01% 531
2024
Q3
$226K Buy
+2,830
New +$213K ﹤0.01% 619
2023
Q3
Sell
-33,278
Closed -$2.72M 642
2023
Q2
$2.72M Hold
33,278
0.04% 435
2023
Q1
$2.47M Buy
33,278
+18,050
+119% +$1.39M 0.04% 461
2022
Q4
$1.26M Sell
15,228
-4,520
-23% -$359K 0.02% 478
2022
Q3
$1.4M Sell
19,748
-72
-0.4% -$6.22K 0.02% 465
2022
Q2
$1.72M Sell
19,820
-7,200
-27% -$675K 0.03% 444
2022
Q1
$2.93M Sell
27,020
-1,480
-5% -$153K 0.04% 380
2021
Q4
$3.69M Buy
28,500
+25,824
+965% +$3.17M 0.05% 364
2021
Q3
$324K Buy
+2,676
New +$326K ﹤0.01% 525

Other funds holding TECH

Swiss Life Asset Management's TECH Position: Q2 2026 in Review

Swiss Life Asset Management increased its Bio-Techne (TECH) stake by 9% in Q2 2026, buying an estimated $49.2K and bringing the position to 10,985 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Swiss Life Asset Management first reported a position in TECH in Q3 2021 and has held it in 16 quarters since. The position peaked at $3.69M in Q4 2021. 379 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Swiss Life Asset Management held 10,985 shares of Bio-Techne worth $776K as of Q2 2026.
  • Swiss Life Asset Management bought 911 Bio-Techne shares in Q2 2026, an estimated $49.2K.
  • Bio-Techne made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #783 holding.
  • Swiss Life Asset Management first reported a position in Bio-Techne in Q3 2021 and has held it in 16 quarters since.
  • Swiss Life Asset Management's Bio-Techne position peaked at $3.69M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.